The Science Behind mRNA Medicines
In using mRNA to develop medicines, we take advantage of normal biological processes to create a desired therapeutic effect. This gives us the potential to treat a broad spectrum of diseases, many of which cannot be addressed with current therapies.
Modalities
We refer to a modality as a family of potential mRNA medicines, consistent both in design and how and where they are delivered in the body. Modalities may focus on different diseases within one therapeutic area - or across therapeutic areas - allowing us to potentially use one technological solution to create medicines for many diseases.
The Technology Driving Our Pipeline
Moderna's Research Engine
Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna and our partners to accelerate the pace of research, from idea development to development candidate nomination.
Moderna's Early Development Engine
Our Norwood, MA manufacturing facility allows us to produce the materials needed to supply our pre-clinical and Phase 1 and Phase 2 clinical development programs and the infrastructure required to anticipate future program demand.
Focused on Corporate Social Responsibility
Moderna's CSR efforts are focused on the development of mRNA medicines - including potential medicines for public health needs - as well as on our employees, the environment, our communities and strong corporate governance.
